LATAM Cargo has reported a substantial 150% rise in pharmaceutical cargo volumes transported between Europe and Brazil from January to July, when compared to the corresponding period of the previous year. This notable increase is predominantly driven by the escalating demand for GLP-1-based medications, which are critical for the treatment of type 2 diabetes.
For freight forwarders and operations managers, this surge highlights a robust and expanding market for air cargo services specializing in pharmaceuticals on the Europe-Brazil trade lane. It suggests potential opportunities for carriers and logistics providers equipped to handle temperature-sensitive and high-value medical shipments. Forwarders should anticipate continued strong demand and potentially stable or rising rates for pharma-specific air freight capacity on this route. This also underscores the importance of reliable cold chain solutions and regulatory compliance for these critical goods.
